rs148884710

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001429.4(EP300):​c.2773C>A​(p.Pro925Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00606 in 1,611,746 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0040 ( 6 hom., cov: 31)
Exomes 𝑓: 0.0063 ( 35 hom. )

Consequence

EP300
NM_001429.4 missense

Scores

3
16

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9O:1

Conservation

PhyloP100: 1.83
Variant links:
Genes affected
EP300 (HGNC:3373): (E1A binding protein p300) This gene encodes the adenovirus E1A-associated cellular p300 transcriptional co-activator protein. It functions as histone acetyltransferase that regulates transcription via chromatin remodeling and is important in the processes of cell proliferation and differentiation. It mediates cAMP-gene regulation by binding specifically to phosphorylated CREB protein. This gene has also been identified as a co-activator of HIF1A (hypoxia-inducible factor 1 alpha), and thus plays a role in the stimulation of hypoxia-induced genes such as VEGF. Defects in this gene are a cause of Rubinstein-Taybi syndrome and may also play a role in epithelial cancer. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009721637).
BP6
Variant 22-41150154-C-A is Benign according to our data. Variant chr22-41150154-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 134039.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-41150154-C-A is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4_exome allele frequency = 0.00628 (9158/1459390) while in subpopulation NFE AF= 0.00749 (8323/1111798). AF 95% confidence interval is 0.00735. There are 35 homozygotes in gnomad4_exome. There are 4390 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 608 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
EP300NM_001429.4 linkuse as main transcriptc.2773C>A p.Pro925Thr missense_variant 14/31 ENST00000263253.9 NP_001420.2
EP300NM_001362843.2 linkuse as main transcriptc.2695C>A p.Pro899Thr missense_variant 13/30 NP_001349772.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
EP300ENST00000263253.9 linkuse as main transcriptc.2773C>A p.Pro925Thr missense_variant 14/311 NM_001429.4 ENSP00000263253 P2
EP300ENST00000674155.1 linkuse as main transcriptc.2695C>A p.Pro899Thr missense_variant 13/30 ENSP00000501078 A2
EP300ENST00000703544.1 linkuse as main transcriptc.*693C>A 3_prime_UTR_variant, NMD_transcript_variant 13/30 ENSP00000515365
EP300ENST00000703545.1 linkuse as main transcriptc.*1143C>A 3_prime_UTR_variant, NMD_transcript_variant 12/17 ENSP00000515366

Frequencies

GnomAD3 genomes
AF:
0.00399
AC:
608
AN:
152238
Hom.:
6
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00137
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00569
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00122
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00628
Gnomad OTH
AF:
0.00621
GnomAD3 exomes
AF:
0.00388
AC:
952
AN:
245168
Hom.:
7
AF XY:
0.00384
AC XY:
511
AN XY:
133040
show subpopulations
Gnomad AFR exome
AF:
0.00145
Gnomad AMR exome
AF:
0.00610
Gnomad ASJ exome
AF:
0.000301
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000886
Gnomad FIN exome
AF:
0.00120
Gnomad NFE exome
AF:
0.00578
Gnomad OTH exome
AF:
0.00463
GnomAD4 exome
AF:
0.00628
AC:
9158
AN:
1459390
Hom.:
35
Cov.:
32
AF XY:
0.00605
AC XY:
4390
AN XY:
726032
show subpopulations
Gnomad4 AFR exome
AF:
0.00105
Gnomad4 AMR exome
AF:
0.00618
Gnomad4 ASJ exome
AF:
0.000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00124
Gnomad4 FIN exome
AF:
0.00136
Gnomad4 NFE exome
AF:
0.00749
Gnomad4 OTH exome
AF:
0.00535
GnomAD4 genome
AF:
0.00399
AC:
608
AN:
152356
Hom.:
6
Cov.:
31
AF XY:
0.00387
AC XY:
288
AN XY:
74514
show subpopulations
Gnomad4 AFR
AF:
0.00137
Gnomad4 AMR
AF:
0.00568
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00122
Gnomad4 NFE
AF:
0.00628
Gnomad4 OTH
AF:
0.00614
Alfa
AF:
0.00542
Hom.:
7
Bravo
AF:
0.00440
TwinsUK
AF:
0.00566
AC:
21
ALSPAC
AF:
0.0112
AC:
43
ESP6500AA
AF:
0.00227
AC:
10
ESP6500EA
AF:
0.00640
AC:
55
ExAC
AF:
0.00364
AC:
442
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00578
EpiControl
AF:
0.00571

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxNov 14, 2018- -
Benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenAug 01, 2024EP300: BS1, BS2 -
Benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsJan 26, 2017- -
not specified Benign:2Other:1
Benign, criteria provided, single submitterclinical testingGenetic Services Laboratory, University of ChicagoSep 26, 2018- -
not provided, no classification providedreference populationITMISep 19, 2013- -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Apr 22, 2015- -
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 25, 2024- -
Rubinstein-Taybi syndrome due to CREBBP mutations Benign:1
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
Colorectal cancer;C3150941:Rubinstein-Taybi syndrome due to EP300 haploinsufficiency;C4551859:Rubinstein-Taybi syndrome due to CREBBP mutations;C5193035:Menke-Hennekam syndrome 2 Benign:1
Likely benign, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsSep 01, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.083
BayesDel_addAF
Benign
-0.29
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
20
DANN
Benign
0.95
DEOGEN2
Uncertain
0.44
T
Eigen
Benign
-0.45
Eigen_PC
Benign
-0.28
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.84
T
M_CAP
Benign
0.025
D
MetaRNN
Benign
0.0097
T
MetaSVM
Benign
-0.56
T
MutationAssessor
Benign
1.8
L
MutationTaster
Benign
0.82
D
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-2.0
N
REVEL
Benign
0.29
Sift
Benign
0.050
D
Sift4G
Benign
0.28
T
Polyphen
0.0080
B
Vest4
0.57
MVP
0.89
ClinPred
0.0095
T
GERP RS
3.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.069
gMVP
0.26

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs148884710; hg19: chr22-41546158; COSMIC: COSV54339374; COSMIC: COSV54339374; API